Neurogene Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	66.63	148.21	82.02	70.54
Short-Term Investments	72.36	48.95	-	-
Cash & Short-Term Investments	138.99	197.16	82.02	70.54
Cash Growth	205.06%	140.37%	16.27%	-
Other Receivables	0.67	0.6	0.99	0.79
Receivables	0.67	0.6	0.99	0.79
Prepaid Expenses	2.38	1.5	1.08	1.91
Other Current Assets	1.6	1.1	0.63	0.71
Total Current Assets	143.65	200.35	84.72	73.96
Property, Plant & Equipment	19.35	20.95	24.55	27.53
Other Long-Term Assets	1.13	1.27	-	-
Total Assets	164.12	222.57	109.27	101.49
Accounts Payable	1.68	2.6	0.63	5.63
Accrued Expenses	9.92	16.76	5.16	4.35
Current Portion of Leases	2.91	2.6	0.7	0.61
Other Current Liabilities	1.29	1.02	0.17	0.27
Total Current Liabilities	15.8	22.97	6.65	10.86
Long-Term Leases	10.21	12.37	3.99	4.6
Other Long-Term Liabilities	0.7	1.21	-	-
Total Liabilities	26.71	36.55	10.64	15.46
Common Stock	-	-	-	0
Additional Paid-In Capital	380.2	373.18	5.1	3.77
Retained Earnings	-242.78	-187.15	-150.84	-95.65
Total Common Equity	137.41	186.02	-145.74	-91.88
Shareholders' Equity	137.41	186.02	98.63	86.03
Total Liabilities & Equity	164.12	222.57	109.27	101.49
Total Debt	13.12	14.97	4.69	5.21
Net Cash (Debt)	125.87	182.19	77.33	65.34
Net Cash Growth	204.41%	135.59%	18.36%	-
Net Cash Per Share	9.79	39.12	196.01	16.13
Filing Date Shares Outstanding	14.85	12.85	5.67	4.05
Total Common Shares Outstanding	13.01	12.82	5.67	4.05
Working Capital	127.85	177.38	78.07	63.1
Book Value Per Share	10.56	14.51	-25.72	-22.68
Tangible Book Value	137.41	186.02	-145.74	-91.88
Tangible Book Value Per Share	10.56	14.51	-25.72	-22.68
Machinery	9.59	9.31	9.04	6.01
Construction In Progress	1.2	0.23	0.25	2.86
Leasehold Improvements	15.4	15.38	15.3	15.29

Source: S&P Capital IQ. Standard template. Financial Sources.